Financial Disclosures
|
|
- Doreen Goodman
- 5 years ago
- Views:
Transcription
1 March 19, 2015 Financial Disclosures Consultant: Alcon Allergan Bausch & Lomb Modernizing Medicine Ophthalmologyweb.co m Investor: Novabay Ophthotech Ocular Surface Disease Ocular surface disease is often multifactorial and requires thorough history, examination, and workup. To keep this presentation within the allotted time frame the focus for this presentation will be on non-infectious causes of dysfunctional tear syndrome 1
2 Symptoms Symptoms include: Dryness Itching Irritation Blurred vision Light sensitivity Foreign body sensation Excessive tearing Symptoms are often exacerbated by: Desiccating environments caused by air conditioner drafts, fan and airplane environments Decreased blink rate from prolonged visual concentration What are some new Diagnostics? Tear film MMP-9 levels Tear film osmolarity Lipid layer evaluation Blood testst Allergy tests Tear Film MMP-9 Matrix metalloproteinases (MMP) are proteolytic enzymes that are produced by stressed epithelial cells on the ocular surface 1 MMP-9 in Tears Non-specific inflammatory marker Normal range between 3-41 ng/ml Correlates with clinical exam findings 1 Ocular surface disease (dry eye) demonstrates elevated levels of MMP-9 in tears 1 [1] Chotiakavanich S, de Paiva CS, Li de Quan, et al. Invest Ophthalmol Vis Sci 2009; 50(7):
3 Dry Eye Disease and MMP-9 MMP-9 in Tears Elevated MMP-9 causes epithelial cell disruption that leads to corneal staining Corneal cell disruption leads to primary ocular symptoms of dry eye including pain, fluctuating vision, and tearing Elevated MMP-9 precedes corneal staining MMP-9 is a more sensitive marker of ocular surface disease than other clinical signs [1] Chotiakavanich S, de Paiva CS, Li de Quan, et al. Invest Ophthalmol Vis Sci 2009; 50(7): Dry Eye Disease and MMP-9 Increased concentrations of MMP-9 can be found in other diseases or conditions, including: Ocular rosacea Meibomian gland disease Sjögren s syndrome Corneal ulcers Corneal erosions MMP-9 Levels in two types of Dry Eye MMP-9 Activity in Tear Samples NL Normal MGD Meibomian Gland Disease EVAPORATIVE DRY EYE SS Sjögren ssyndrome AQUEOUS DEFICIENCY P < compared with normal subjects [1] Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci Sep;42(10):
4 Inflammadry Intended Use InflammaDry is a rapid, immunoassay test for the visual, qualitative in vitro detection of elevated levels of the MMP-9 protein in human tears from patients suspected of having dry eye. InflammaDry is to be used to aid in the diagnosis of dry eye, in conjunction with other methods of clinical evaluation. This test is intended for prescription use at point-of-care sites. Inflammadry Test Test includes 1 foil pouch containing a sterile sample collector 1 foil pouch containing a test cassette 1 buffer vial Shelf life = 24 months Store InflammaDry between 39 and 77 F (4-25 C) Assembled Test Inflammadry 4-Step Process * * Release the lid after every 2-3 dabs. Allow the sampling fleece to rest along the conjunctiva for 5 seconds. 4
5 Tear Osmolarity Measuring osmolarity allows us to evaluate an objective physiologic marker rather than relying only on subjective signs of the diseasesuch such asstainingstaining or tear break up time. Inter Eye Differences The DED process is characterized by a loss of tear film homeostasis resulting in hyperosmolarity and an unstable tear film An inter-eye difference >8 mosm/l is an indication of tear film instability, frequently an early manifestation in the development of disease DED is a bilateral and often asymmetrical disease Normal Tear Film Tears in proper homeostasis should be equivalent to blood osmolarity which is between mosm/l Inter eye osmolarity difference should be <8 mosm/l International Dry Eye Workshop (DEWS). The definition & classification of dry eye disease. Ocul Surf Lemp MA, Bron AJ, Baudouin C, Benítez Del Castillo JM, Geffen D, Tauber J, Foulks GN, Pepose JS, Sullivan BD. Tear osmolarity in the diagnosis and management of dry eye disease. Am. J. Ophthalmol May; 151(5): Keech A, Senchyna M, Jones L. Impact of time between collection and collection method on human tear fluid osmolarity. Curr. Eye Res Apr; 38(4): Hyperosmolarity Upregulates EMMPRIN/MMP-9 Huet E et al. Am J Pathol. 2011;179. 5
6 Hyperosmolarity Causes loss of Microplicae on the Corneal Epithelium Andrews PM. Journal Cell Bio. 1976;68: Measurement of Both Eyes is Essential MAXIMUM of the two eyes: >300 mosm/l demonstrates loss of homeostasis and likely to become pathogenic >308 DIFFERENCE between two eyes: Shows the stability of the tear film. Normal tears are stable and <300 mosm/l bilaterally. A difference of >8 mosm/l is a hallmark of tear instability Effect of Compensatory Mechanisms in Early Stage DED Blinking, aqueous tearing (mixing), increased lipid secretion excretion - all lower osmolarity transiently and asymmetrically < 5 mosm/l Variability mosm/l > 20 mosm/l A Bron, et al. The Ocular Surface 2009 Apr;7(2) A Keech, et al. Curr Eye Res 2013 Apr;38(4)
7 Understanding Tear Film Instability in Dry Eye Normal subjects exhibit low and stable osmolarity Normal tear osmolarity = Equivalent to blood osmolarity = mosm/l Indicative of the tears being held in proper homeostasis Dry Eye subjects exhibit elevated and unstable osmolarity Osmolarity changes between eyes and over time Inter eye difference = hallmark of DED 1 ( > 8 mosm/l between eyes) 1 Lemp MA et al., Am J Ophthalmol May;151(5): What if TO is normal but the ocular surface and/or symptoms indicate dry eye? Normal osmolarity but ocular surface irritation/complaints Partially treated DED Conjunctival chalasis CLand/or solution irritation Mild allergic conjunctivitis Epithelial Basement Membrane Dystrophy Pinguecula/early pterygia Infection Anterior blepharitis Demodex TearLab Osmolarity Testing Perform TearLab Osmolarity testing before other tests Wait 15 minutes after topical anesthetic and/or dilating drops Wait at least 2 hours after any other topically applied drops including artificial tears TearLab Test Card collects 50 nanoliters of fluid from the tear meniscus Results available within seconds The test can be performed by a technician 7
8 What if TO is elevated but the ocular surface is quiet and/or the patient is asymptomatic? Hyperosmolarity is a hallmark sign of DED as stated in dozens of peer review publications over the past 5 years and even decades of research prior to the development of TearLab (> 250 publications) The patient may not have reached hda point where visible iibl evidence is present e.g. corneal staining which is typically a late sign for DED and can also be present in other OSD conditions We now are seeing many publications showing hyperosmolarity can cause damage to corneal nerves leaving a neurotrophic condition with poor symptom recognition What if TO is normal but the ocular surface and/or symptoms indicate dry eye? Signs and symptoms do not correlate with each other and this also includes osmolarity There is significant overlap with other OSD conditions such as ocular allergy, conjunctival chalasis, etc. Patient may be partially treated Subjectivity of patient symptoms (e.g. stoic vs. whiner) Korb Meibomian Gland Evaluator First standardized metric to verify the presence of meibomian gland dysfunction. By mimicking the pressure of a deliberate blink ( g/mm2), the Korb MGE allows the eye care professional to assess meibomian gland secretions and function at the slit lamp. The Korb MGE also tracks the progression of MGD and non-obvious obvious MGD with visit-to to-visit consistency and repeatability. Korb & Blackie, Cornea 2008; 27:
9 Meiboscale AB F 29 yo LM F 56 yo SR F 51 yo Normal Truncated Severely Truncated ES F 22 yo Dilated Ducts AS F 58 yo Truncated Sjo 9
10 Allergy Testing Doctors Allergy Formula Doctor Allergy Matrix Newer Treatments Amniotic grafts Autologous serum tears Lacrisert Lipiflowifl IPL Laser Off label therapy (Tacrolimus/testosterone) Amniotic grafts 10
11 Amniotic Grafts BioD BioTissue (Prokera/Ambiograft) IOP Moria Seed Biotech Lacrisert Lipiflow 11
12 Lipiflow Korb, DR, Blackie, CA. Meibomian gland therapeutic expression: quantifying the applied pressure and the limitation of resulting pain. Eye Contact Lens Sep;37(5): IPL Laser Thank You 12
Tear Osmolarity and its role in Optometric Practice & Contact Lens Success
Tear Osmolarity and its role in Optometric Practice & Contact Lens Success Nick Dash: Optometrist Declaration of Association Director: See2wiN Ltd (Accuvision/Visual Edge/SportsVision Institute) Honorary
More informationEvidence for Technology in the Treatment of Advanced Dry Eye
Evidence for Technology in the Treatment of Advanced Dry Eye COPE 44435-AS Chris Lievens, OD, MS, FAAO Evidence for Technology in the Treatment of Advanced Dry Eye COPE: 44435-AS Chris Lievens, OD MS FAAO
More informationOptimizing the Ocular Surface. Presentation Title. Charlene M. Grice, Carolina Eyecare Physicians, LLC
Optimizing the Ocular Surface Presentation Title Presenter Charlene M. Grice, Name MD Carolina Eyecare Physicians, LLC Financial Disclosures I have no financial disclosures. I will discuss off label use
More informationAdvanced Diagnosis and Management of OSD and Tear Dysfunction
Advanced Diagnosis and Management of OSD and Tear Dysfunction Arthur B. Epstein, OD, FAAO Phoenix, Eye Care & The Dry Eye Center of Arizona Phoenix, AZ, USA Our understanding of the ocular surface has
More informationHow to Create a Dry Eye Center
How to Create a Dry Eye Center Whitney Hauser, OD Signal Ophthalmic Consulting Disclosures TearScience Consultant/Speaker NovaBay Speaker BioTissue - Speaker Lumenis Consultant/Speaker Shire Consultant/Speaker
More informationVisionary Optics. SynergEyes. North Suburban Vision Consultants, Ltd. Keratoconus Specialists of Illinois. S. Barry Eiden, OD, FAAO
New Technologies in the diagnosis and management of dry Eye S. Barry Eiden, OD, FAAO North Suburban Vision Consultants, Ltd. Keratoconus Specialists of Illinois International Keratoconus Academy EyeVis
More informationRECENT ADVANCES IN THE MANAGEMENT AND TREATMENT OF DRY EYE DISEASE
RECENT ADVANCES IN THE MANAGEMENT AND TREATMENT OF DRY EYE DISEASE FRANCESCO CARONES, MD MEDICAL DIRECTOR AND PHYSICIAN CEO CARONES VISION, MILAN - ITALY FINANCIAL DISCLOSURES Francesco Carones, MD consults
More informationOcular Surface Disease. Advanced Treatment in Ocular Surface Disease. Disclosures. Revenue Potential. Chronic Dry Eye Should I Treat It
Advanced Treatment in Ocular Surface Disease Douglas K. Devries, O.D. Eye Care Associates of Nevada Douglas K. Devries Consultant or Speakers Bureau for Allergan AMO TearLab NicOx BVI B&L Disclosures Chronic
More informationMEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY?
MEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY? Alan G. Kabat, OD, FAAO (901) 252-3691 Memphis, Tennessee alan.kabat@alankabat.com Course description: This course reviews the latest thoughts,
More informationDry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D Kensington Blvd. Bowling Green, OH 43402
Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D. 1409 Kensington Blvd. Bowling Green, OH 43402 Summary As our understanding of dry eye disease has evolved, so
More information1. Department of Ophthalmology, Pacific Medical College and Hospital, Udaipur, Rajasthan, India
International Journal of Medical Science and Education An official Publication of Association for Scientific and Medical Education (ASME) www.ijmse.com Original Research Article pissn- 2348 4438 eissn-2349-3208
More informationLearn Connect Succeed. JCAHPO Regional Meetings 2017
Learn Connect Succeed JCAHPO Regional Meetings 2017 Unveiling Dry Eye Evaluation LOOKING AT DRY EYE DIFFERENTLY: GAINING KNOWLEDGE AND SKILL BY MARTHA TELLO, COMT,OSC, BGS JCAHPO MIAMI, FLORIDA CONTINUING
More informationConsidering Inflammation in Dry Eye Disease. Scott E. Schachter, O.D. Vision Source-Pismo Beach, CA
Considering Inflammation in Dry Eye Disease Scott E. Schachter, O.D. Vision Source-Pismo Beach, CA 1 We will cover. Dry Eye Characteristics Diagnostics and Treatments Evaporative dry eye (MGD) vs Aqueous
More informationVARIABILITY IS A HALLMARK OF DRY EYE DISEASE
VARIABILITY IS A HALLMARK OF DRY EYE DISEASE Christopher E. Starr, MD, FACS Associate Professor of Ophthalmology Director, Refractive Surgery Director, Cornea, Cataract & Refractive Surgery Fellowship
More informationMeibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK)
Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK) David Bruton, Jr. Professor of Ophthalmology Chairman, Department of Ophthalmology The University of Texas Southwestern
More informationTear Structure. Structure = Stability. Disclosures. In Depth Management of Ocular Surface & Tear Film Disorders UNDERSTANDING THE OCULAR SURFACE
Disclosures Arthur Epstein, OD, FAAO In Depth Management of Ocular Surface & Tear Film Disorders Art Epstein, OD, FAAO Dry Eye Center of Arizona Phoenix Eye Care Phoenix, AZ, USA All views in this talk,
More informationTitle: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD
Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD Course Description: The Dry Eye Workshop 2 was an assemblage of experts in dry eye disease from around the world,
More informationMicroblepharoexfoliation for the Surgical Dry Eye Patient. Frank W. Bowden, III, M.D., FACS
Microblepharoexfoliation for the Surgical Dry Eye Patient Frank W. Bowden, III, M.D., FACS Disclosures Shire TearScience TearLab RySurg Bausch & Lomb/Valeant BioTissue Surgical Dry Eye The surgical dry
More information10/27/2017. Evidence for Technology in the Treatment of Dry Eye COPE: AS. Dry eye. Dry eye
Evidence for Technology in the Treatment of Dry Eye COPE: 44090-AS Chris Lievens, OD MS FAAO Professor Chief of staff Southern college of optometry Dry eye Chronic Multifactorial Characterized by disturbances
More informationDoes in-office manual expression for Meibomian Gland Dysfunction (MGD) work?
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/282816021 Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work? Conference
More informationConsulting Bausch+Lomb/Valeant, NovaBay (Avenova), Google, Allergan, Vistakon, Alcon
MGD Joe Barr, OD, MS, FAAO Emeritus Professor, The Ohio State University barr.2@osu.edu Financial Disclosures Stock holder: Envision, Access Media (not a major shareholder), Tree House, SMM Consulting
More informationCurrent Treatment and Management of Dry Eye
Current Treatment and Management of Dry Eye David I. Geffen, OD, FAAO David I Geffen, OD, FAAO Consultant/Advisor/Speaker Accufocus Alcon AMO Annidis Bausch + Lomb Bruder Healthcare EyeBrain Optovue Revision
More informationDry Eye Disease Update
Dry Eye Disease Update Feb 2013 Dr. Samuel Kim Director of Physician Training earscience, Inc. skim@tearscience.com Iconoclasts The Dr. Who Drank Infectious Broth, Gave Himself an Ulcer, and Solved a Medical
More informationNo Conflict of Interest to Report Charles Stockwell, O.D
OH MY!!! DRY EYE!!! No Conflict of Interest to Report Charles Stockwell, O.D Charles.stockwell@ttuhsc.edu The Problem 1 Filamentary Keratitis Keratoconjunctivitis sicca, or dry eye syndrome, is the most
More informationA DRY EYE DISEASE DECISION TREE
A DRY EYE DISEASE DECISION TREE With the DEWS guidelines almost 10 years old, new approaches are needed. BY JASON SCHMIT, OD I am sometimes asked about medical decision-making by students, interns, fellows,
More informationThe first comprehensive definition of DED was published in
Special Issue Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions Jun Shimazaki Department of Ophthalmology, Tokyo Dental College, Ichikawa General Hospital,
More informationOcular Surface Disease Workshop Walter O. Whitley, OD, MBA, FAAO Michael Cooper, OD Whitney Hauser, OD Scott Hauswirth, OD, FAAO
Ocular Surface Disease Workshop Walter O. Whitley, OD, MBA, FAAO Michael Cooper, OD Whitney Hauser, OD Scott Hauswirth, OD, FAAO Description As our understanding of the ocular surface spectrum has evolved,
More informationOCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY
OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY SURFACE DISEASE DRY EYE DYSFUNCTIONAL TEARS SYND ALLERGIC DISORDERS MEIBOMIAN GLAND PROBLEMS OCULAR IMMUNE
More informationImprove the Diagnosis, Management and Treatment of Inflammatory Dry Eye
Improve the Diagnosis, Management and Treatment of Inflammatory Dry Eye USING INFLAMMADRY TO IDENTIFY INFLAMMATION IN DRY EYE PATIENTS FACILITATES TARGETED TREATMENT AND BETTER OUTCOMES. HIGHLIGHTS FROM
More information1/16/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX.
William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX drbilltownsend@gmail.com 1 Alcon CIBA Odyssey Medical Science Based Health Shire TearLab Any product
More informationREAL-WORLD UTILIZATION PATTERNS OF CYCLOSPORINE OPHTHALMIC EMULSION 0.05% WITHIN MANAGED CARE
REAL-WORLD UTILIZATION PATTERNS OF CYCLOSPORINE OPHTHALMIC EMULSION 0.05% WITHIN MANAGED CARE Tina H Chiang 1, John G Walt 1, John P McMahon, Jr. 2, James E Mansfield, Jr. 2, Susan Simonyi 3 1 Allergan
More informationDry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM
Page 1 of 13 BEFORE COMPLETING THE OCULAR EXAMINATION, YOU MUST BE ABLE TO ANSWER YES TO THE FOLLOWING QUESTIONS: Have you done MMP9? (SVonly) The Following are done at Baseline: Have you done Tear Osmolarity?
More informationDiagnostics. Traditionally, clinicians have made the diagnosis. cover story. Join the renaissance!
Dry Eye Diagnostics Join the renaissance! By John D. Sheppard, MD, MMSc Traditionally, clinicians have made the diagnosis of dry eye disease (DED) based on a patient s history, slit-lamp examination, Schirmer
More informationDry eye disease was recently redefined as a multifactorial
CLINICAL SCIENCE Ocular Surface Workup With Automated Noninvasive Measurements for the Diagnosis of Meibomian Gland Dysfunction Giuseppe Giannaccare, MD, PhD,* Luca Vigo, MD, Marco Pellegrini, MD,* Stefano
More informationBREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE
BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE In this article, Christian Roesky, PhD, Chief Executive Officer, Novaliq, discusses the underserved condition of dry eye disease, and presents two products
More informationOS3 The TearLab Ocular Surface Severity Scale Benjamin D. Sullivan, Ph.D. (760)
OS3 The TearLab Ocular Surface Severity Scale Benjamin D. Sullivan, Ph.D. bdsulliv@tearlab.com (760) 224-4595 The Ocular Surface Severity Scale (OS 3 ) was originally developed as a way to compare the
More informationCorrelation of Bacterial Burden, Meibomian Gland Dysfunction and Ocular Surface Disease
Correlation of Bacterial Burden, Meibomian Gland Dysfunction and Ocular Surface Disease Alanna S. Nattis, DO Eric D. Rosenberg, DO Marcelle Morcos, MD Eric D. Donnenfeld, MD Michael Reinsbach, MD Henry
More informationAlthough the prevalence
Supplement to EyeWorld April 2016 2016 Ocular Surface Disease The impact of ocular surface dysfunction on surgical outcomes: Evidence-based insights on diagnostic tools to guide treatments The impact of
More informationOverview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye...
Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye... This Allergan sponsored session was held on July 24, 2005, Hotel Satya Ashoka, Jabalpur. The session was followed
More informationComparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon A silicone hydrogel
Int Ophthalmol (2012) 32:229 233 DOI 10.1007/s10792-012-9556-y ORIGINAL PAPER Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon
More informationA Systematic Approach to Dry Eye using LipiFlow Treatment. Mitchell A Jackson, MD. Founder/CEO, Jacksoneye, Lake Villa, Illinois, US
A Systematic Approach to Dry Eye using LipiFlow Treatment Mitchell A Jackson, MD Founder/CEO, Jacksoneye, Lake Villa, Illinois, US Abstract The complex strategy to understanding dry eye syndrome has led
More informationManaging Dry Eye Disease
Today s Methods for Managing Dry Eye Disease A panel of renowned eye doctors share their day-to-day approaches to detecting, treating and managing patients with this common condition. Supported by Sponsored
More informationMeibomian gland dysfunction
SPECIAL REPORT Meibomian gland dysfunction June 2011 The mere formulation of a problem is far more essential than its solution To raise new questions, new possibilities, to regard old problems from a new
More informationStrategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH
Strategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH 43402 brujic@prodigy.net 419-261-9161 Summary As optometry s scope of practice continues
More informationDry Eye Prescribing Guidelines
Dry Eye Prescribing Guidelines Amendment History VERSION DATE AMENDMENT HISTORY V1.0 2011 Comments V1.1 2013 Updated V1.1 2017 Draft Updated Thealoz Duo replaces carmellose Optive in severe dry eye on
More informationOphthalmology Times Case Study Yasmin Mali, MD. Case Study
Ophthalmology Times Case Study Yasmin Mali, MD Case Study A 57 year old female with presented with ocular irritation and discomfort in both eyes for several months. Patient was previously started on a
More informationAn Update on Diagnosis and Treatment of Refractory Ocular Surface Disease
An Update on Diagnosis and Treatment of Refractory Ocular Surface Disease Kendall E. Donaldson, MD, MS Associate Professor of Ophthalmology Bascom Palmer Eye Institute Royal Hawaiian Eye, Maui, HI 2018
More informationEyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome
Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Policy Number: 9.03.29 Last Review: 12/2017 Origination: 9/2013 Next Review: 5/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue
More informationBreaking the Cycle. Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai
Lin, Garg Ophthalmology Times 1 Breaking the Cycle Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai Abstract A 32 year-old female with a history of LASIK surgery
More informationOverview. NEI Definition of Dry Eye. Prevalence of Dry Eye 2/1/2018. The Dry Eye Story A Real Tear Jerker. Disclosures
Percentage of Responses Percentage of Responses 2/1/2018 The Dry Eye Story A Real Tear Jerker Disclosures University of Houston College of Optometry njoy Vision Center BioTissue, Inc. OCuSOFT, Inc. Shire
More informationCase no.4. Subjective. Subjective (2) Caucasian female, 62 Y.O., consulting for a XXX opinion on her condition.
Case no.4 Contact lenses: cause Subjective Caucasian female, 62 Y.O., consulting for a XXX opinion on her condition. Works as a lab technician for a veterenary surgeon No exposure to chemicals Had been
More informationBruce H. Koffler, M.D. Lindsay Koffler Cassidy, COT, OSC
Bruce H. Koffler, M.D. Lindsay Koffler Cassidy, COT, OSC Ocular surface disease patients can be very time consuming. You must have a streamlined system and work as a team in order to effectively run a
More information1/23/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX.
William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX drbilltownsend@gmail.com 1 Alcon CIBA Odyssey Medical Science Based Health Shire TearLab Any product
More informationEvaluation of Dry Eye: A Hospital Based Study
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 9 Ver. XI (September. 2017), PP 44-49 www.iosrjournals.org Evaluation of : A Hospital Based
More informationDry Eye Syndrome Prescribing Guidelines
Dry Eye Syndrome Prescribing Guidelines Dry Eye Syndrome is a group of disorders of the ocular surface related to tear film abnormality, associated with ocular discomfort, visual symptoms and objective
More informationUnderstanding the Role of Meibomian Gland Dysfunction in Dry Eyes
Understanding the Role of Meibomian Gland Dysfunction in Dry Eyes The International Dry Eye Workshop separated dry eyes into two main categories in 2007. Aqueous Deficient Dry Eyes as defined by an inability
More informationQUALITATIVE INTERPRETATION OF VISUAL ACUITY IN DRY EYE PATIENTS
Bulletin of the Transilvania University of Braşov Special Issue Series VI: Medical Sciences Vol. 10 (59) No. 2-2017 QUALITATIVE INTERPRETATION OF VISUAL ACUITY IN DRY EYE PATIENTS C. TRIHENEA 1 A. STANILA
More informationPROFILE OF MEIBOMIAN GLANDS IN MEIBOMIAN GLAND DYSFUNCTION
International Journal of Medical Science and Education An official Publication of Association for Scientific and Medical Education (ASME) Original Research Article BACTERIOLOGICAL PROFILE OF MEIBOMIAN
More informationForward Looking Statements
Forward Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include but are not limited
More informationIncidence Of Dry Eye Disesase In People Living With Acquired Immuodeficiency Synrome
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 9 Ver. X (September). 2016), PP 41-46 www.iosrjournals.org Incidence Of Dry Eye Disesase In
More informationMatrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease
Article https://doi.org/10.1167/tvst.7.5.31 Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease Jae Yong Park 1, Bum Gi Kim
More informationMedical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.
ADVANCED BENEFICIARY NOTICE (ABN) Patient s Name: Date of Birth: The purpose of this form is to help you make an informed choice about your visit today. Before you make a decision about your options, you
More informationEyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome
Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Policy Number: 9.03.29 Last Review: 5/2018 Origination: 9/2013 Next Review: 11/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue
More informationDry eye update: new diagnostic and management strategies
Contact Lens Update CLINICAL INSIGHTS BASED IN CURRENT RESEARCH February 27, 2018 Sruthi Srinivasan is a clinical research manager at the Centre for Ocular Research & Education, and a research assistant
More informationpat hways Medtech innovation briefing Published: 15 December 2015 nice.org.uk/guidance/mib47
pat hways TearLab osmolarity system for diagnosing dry eye disease Medtech innovation briefing Published: 15 December 2015 nice.org.uk/guidance/mib47 Summary The TearLab osmolarity system is a point-of-care
More informationCurrent Practice Pattern for Dry Eye Patients in South Korea: A Multicenter Study
pissn: 11-8942 eissn: 92-9382 Korean J Ophthalmol 14;28(2):115-121 http://dx.doi.org/.3341/kjo.14.28.2.115 Original Article Current Practice Pattern for Dry Eye Patients in South Korea: A Multicenter Study
More informationDry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6
Dry eye syndrome The aim of this information sheet is to answer any questions you may have about dry eye syndrome. If you have any further questions or concerns, please ask a doctor or nurse caring for
More information1998 DESCRIPTION Evaluation of Subjective and Objective tests for diagnosing tear-film disorders known to cause ocular irritation.
DEWS DRY EYE: DIAGNOSTIC TEST TEMPLATE RAPPORTEUR A.J.Bron 18 th Oct 2004 TEST Mixed tests TO Ocular Irritation / Dry Eye REFERENCES DIAGNOSE VERSION of TEST Multiple tests DESCRIPTION Evaluation of Subjective
More informationD RY E YE C LINIC AT THE O FFICE OF D R. D AVID R. F RAZEE
D RY E YE C LINIC AT THE O FFICE OF D R. D AVID R. F RAZEE RECLAIMING THE DRY EYE PATIENT During the past decade, the world of dry eye disease (DED) has undergone some exciting evolutions. There are so
More informationOphthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary
Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,4 Agent Indication Dosage and Administration Restasis (cyclosporine ophthalmic emulsion)
More informationAutologous Serum The How. Anterior Segment Disease Therapy: A Look Into The Future Eric E. Schmidt, O.D., F.A.A.O. Omni Eye Specialists Wilmington, NC
Anterior Segment Disease Therapy: A Look Into The Future Eric E. Schmidt, O.D., F.A.A.O. Omni Eye Specialists Wilmington, NC Actually The Future May Be Now!! Autologous Serum The How More aptly called
More informationLocal Coverage Determination (LCD): Diagnostic Evaluation and Medical Management of Moderate-Severe Dry Eye Disease (DED) (L36232)
Local Coverage Determination (LCD): Diagnostic Evaluation and Medical Management of Moderate-Severe Dry Eye Disease (DED) (L36232) Links in PDF documents are not guaranteed to work. To follow a web link,
More informationStore between 39 F to 77 F (4 C to 25 C). Not to be taken internally. Keep out of reach of children.
CLIA Complexity: WAIVED For in vitro diagnostic use, Rx only. A CLIA Certificate of Waiver is required to perform the test in a waived setting. To obtain a Certificate of Waiver, please contact your state
More informationScottish Dry Eye Guidelines
Scottish Dry Eye Guidelines VERSION 1.1 September 2018 Scottish Dry Eye Guidelines, version 1.1, September 2018 Contents Contents 1 Introduction 1 Dry Eye Working Group 1 Contributors to Dry Eye Working
More informationPrevalence of dry eye disease in type 2 diabetic patients and its co-relation with the duration, glycemic control and retinopathy
Al Am een J Med Sci 2015; 8(3):225-229 US National Library of Medicine enlisted journal ISSN 0974-1143 SHORT COMM UN ICAT ION C O D E N : A A J MB G Prevalence of dry eye disease in type 2 diabetic patients
More informationOcular Surface Disease: Accurately Diagnose & Effectively Treat Your Surgical Patients
Supplement April 2018 Ocular Surface Disease: Accurately Diagnose & Effectively Treat Your Surgical Patients Supported by an unrestricted educational grant from Prevalence of Ocular Surface Disease and
More informationImmunology and Pathophysiology of Dry Eye
Immunology and Pathophysiology of Dry Eye Associate Prof. Banu Bozkurt, MD, FEBO MSc in Immunology Selcuk University Medical Faculty, Konya, Turkey 47th PanHellenic Ophthalmology Congress 28-31 May 2014,
More informationA Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction
CLINICAL SCIENCE A Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction Pinnita Prabhasawat, MD, Nattaporn Tesavibul, MD, and Wannaree
More informationDr.Sushil Kumar Tripathi
Rabamipide:360 Benefits in Dry eye syndrome Dr.Sushil Kumar Tripathi Prevalence of Dry Eye Syndrome: vone in four patients attending ophthalmic clinics report symptoms of dry eye. vprevalence of dry eye
More informationHELP HEAL YOUR PATIENTS DRY EYES.
HELP HEAL YOUR PATIENTS DRY EYES. REFRESH REPAIR promotes healing of the cornea and conjunctival epithelia, and improves visual performance in Dry Eye patients. REF115081_v2 12/18 FIRST AND ONLY ARTIFICIAL
More informationThe Tear Film! Cataract Surgery in the Diseased Eye: Ocular Surface Disease
Cataract Surgery in the Diseased Eye: Ocular Surface Disease I am a consultant to Allergan, Alcon, B&L, and Tear Science I have no financial interest in any product discussed herein Parag A. Majmudar,
More informationJMSCR Vol 05 Issue 02 Page February 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i2.155 Prevalence of Dry Eye Diseases in the
More informationA Study of Dry Eye Disorder in Elderly Persons of Western Rajasthan
Original Article A Study of Dry Eye Disorder in Elderly Persons of Western Rajasthan Avisha Mathur 1, Arvind Chauhan 2 Abstract Introduction: Dry eye syndrome is one of the most frequently encountered
More informationPredisposing factors. Gender. Ocular Surface Disease. Ocular Surface Disease Health. Building a Dry Eye Practice
Ocular Surface Disease Health Building a Dry Eye Practice Paul M. Karpecki, OD, FAAO Koffler Vision Group Lexington, KY Discuss the associated pathology of dry eye Discuss modalities of diagnosis, etiology
More informationPardon the Objection: Cases Marc R. Bloomenstein OD, FAAO Scot Morris, OD Derek Cunningham, OD Kathy Mastrota, OD
I. Introduction a. Treating the anterior segment different for each patient b. How can new technology help your patients? c. The anterior segment is going to be the hot bed for new technology II. Lipiflow
More informationDry Eye That s Not Dry Eye
Dry Eye That s Not Dry Eye All burning, irritated eyes aren t dry eye. This course will present several anterior segment cases that were initially misdiagnosed as Dry Eye Disease. Attendees will be offered
More informationConjunctivochalasis (Cch) is described as lax and redundant. The Impact of Conjunctivochalasis on Dry Eye Symptoms and Signs
Clinical and Epidemiologic Research The Impact of Conjunctivochalasis on Dry Eye Symptoms and Signs Priyanka Chhadva, 1,2 Abigail Alexander, 1 Allison L. McClellan, 3 Katherine T. McManus, 3 Benjamin Seiden,
More informationUNDERSTANDING DRY EYE TREATMENT AND PROTOCOL
UNDERSTANDING DRY EYE TREATMENT AND PROTOCOL Tim Trinh, O.D., F.A.A.O. Box Medical Solutions Date: September 19 th, 2017 Tim.trinh@boxmedicalsolutions.com www.boxmedicalsolutions.com The Definition and
More informationPrevalence of Dry Eye Disease
Managing the Psychology of Dry Eye Disease The Role of Diagnostics Richard A. Adler, MD, FACS Director, Belecara Ophthalmology Assistant Professor of Ophthalmology Wilmer Eye Institute, Baltimore, Maryland
More informationMedical and/or Vision Insurance plans do not cover the Specialty Dry Eye Testing or LipiFlow services.
ADVANCED BENEFICIARY NOTICE (ABN) Patient s Name: Date of Birth: The purpose of this form is to help you make an informed choice about your visit today. Before you make a decision about your options, you
More informationDry eye disease is multifactorial in aetiology and complex in pathophysiology that makes its diagnosis clinically challenging.
Diagnostic Tools for Dry Eye Disease Sarah Dougherty Wood and Shahzad I Mian Department of Ophthalmology and Visual Sciences, Medical School, University of Michigan, Ann Arbor, Michigan, US DOI: https://doi.org/10.17925/eor.2016.10.02.101
More informationInflammatory Cytokine and Osmolarity Changes in the Tears of Dry Eye Patients Treated with Topical 1% Methylprednisolone
Original Article http://dx.doi.org/10.3349/ymj.2014.55.1.203 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 55(1):203-208, 2014 Inflammatory Cytokine and Osmolarity Changes in the Tears of Dry Eye Patients
More informationDRY EYE TAKING AIM. How Systematic Management of this Chronic Disease is Improving Patient Outcomes. Sponsored by. A Supplement to
TAKING AIM AT DRY EYE How Systematic Management of this Chronic Disease is Improving Patient Outcomes A Supplement to Sponsored by THERAPY FOR YOUR EYES Taking Aim at Dry Eye How Systematic Management
More information2007 M.D. Clinical Medicine Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, P. R. China
Date Prepared: August 9, 2017 Name: Yang Liu Office Address: Schepens Eye Research Institute, 20 Staniford Street, Boston, MA 02114 Work Phone: 617-912-0288 Work Email: yang_liu@meei.harvard.edu Education:
More informationIPL for the management of MGD/DED. Dr. Jeffrey Judelson, FRCSC
IPL for the management of MGD/DED Dr. Jeffrey Judelson, FRCSC IPL presentation Introduction to IPL Clinical evaluation of DED/MGD Overview of management multifaceted approach DED/MGD basics Prevalence
More informationOVERCOMING THE CHALLENGES OF OPHTHALMIC DELIVERY USING AQUEOUS-FREE TECHNOLOGY: REDEFINING DRY EYE DISEASE
OVERCOMING THE CHALLENGES OF OPHTHALMIC DELIVERY USING AQUEOUS-FREE TECHNOLOGY: REDEFINING DRY EYE DISEASE Traditional aqueous vehicles for topical ophthalmic medications suffer from a number of limitations.
More informationDry Eye Disease: Advancements in Therapy. Amanda Salter, M.D.
Dry Eye Disease: Advancements in Therapy Amanda Salter, M.D. What We Will Cover Dry eye definition and background information Associated conditions and risk factors Brief overview of dry eye pathophysiology
More informationCurrent Management and Treatment of Dry Eye Disease
DOI: 10.4274/tjo.69320 Turk J Ophthalmol 2018;48:309-313 Review Current Management and Treatment of Dry Eye Disease Cem Şimşek, Murat Doğru, Takashi Kojima, Kazuo Tsubota Keio University Faculty of Medicine,
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION Contents METHODS... 2 Inclusion and exclusion criteria... 2 Supplementary table S1... 2 Assessment of abnormal ocular signs and symptoms... 3 Supplementary table S2... 3 Ocular
More informationOOGZIEKTEN VOOR DE HUISARTS F. GOES, JR.
OOGZIEKTEN VOOR DE HUISARTS F. GOES, JR. HET RODE OOG F. GOES, JR. Condition Signs Symptoms Causes Conjunctivitis Viral Normal vision, normal pupil size Mild to no pain, diffuse Adenovirus (most common),
More information